Association of Vitamin D with Severity and Outcome of COVID-19: Clinical and Experimental Evidence
Journal of Innate Immunity · 2024 · 16 (1) · 1-11
DOI: 10.1159/000535302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, online erschienen am 26.11.2023. Verfasst von Georgios Renieris und 9 weiteren Autor:innen. Beteiligte Einrichtung: 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: COVID-19, Vitamin D Deficiency. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The role of vitamin in COVID-19 remains controversial. We investigated the association between endogenous vitamin D and the severity of COVID-19 as well as the mechanisms of action of vitamin D supplementation.
Methods
25(OH)D3 in serum was associated with disease severity and outcome in 190 COVID-19 patients. In a COVID-19 animal model using intravenous injection of plasma from patients with COVID-19 acute respiratory distress syndrome into C57/BL6 mice, mice were treated with 0.25 μg human 1,25(OH)D3 or vehicle. Mice were sacrificed on day 4. Cytokines and myeloperoxidase (MPO) in tissues were measured. Changes in gene expression after vitamin D supplementation were measured.
Results
Vitamin D deficiency and insufficiency were associated with increased severity and unfavorable outcome after 28 days. Vitamin D levels were negatively associated with biomarkers of COVID-19 severity. Vitamin D supplementation after challenge of mice with COVID-19 plasma led to reduced levels of TNFα, IL-6, IFNγ, and MPO in the lung, as well as down-regulation of pro-inflammatory pathways.
Conclusion
Normal levels of endogenous vitamin D are associated with reduced severity and risk of unfavorable outcome in COVID-19, possibly through attenuation of tissue-specific hyperinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- Greek Genome Center, Biomedical Research Foundation (BRFAA) of the Academy of Athens, Athens, Greece.
Zitieren
APA
Renieris, G., Foutadakis, S., Andriopoulou, T., Spanou, V. M., Droggiti, D. E., Kafousopoulos, D., Gkavogianni, T., Damoraki, G., Vatsellas, G., & Giamarellos-Bourboulis, E. J. (2024). Association of Vitamin D with Severity and Outcome of COVID-19: Clinical and Experimental Evidence. Journal of Innate Immunity, 16(1), 1-11. https://doi.org/10.1159/000535302
Vancouver
Renieris G, Foutadakis S, Andriopoulou T, Spanou VM, Droggiti DE, Kafousopoulos D, et al. Association of Vitamin D with Severity and Outcome of COVID-19: Clinical and Experimental Evidence. Journal of Innate Immunity. 2024;16(1):1-11. doi:10.1159/000535302
BibTeX
@article{Renieris2024,
author = {Renieris, Georgios and Foutadakis, Spyros and Andriopoulou, Theano and Spanou, Victoria-Marina and Droggiti, Dionyssia-Eirini and Kafousopoulos, Dionysios and Gkavogianni, Theologia and Damoraki, Georgia and Vatsellas, Giannis and Giamarellos-Bourboulis, Evangelos J},
title = {Association of Vitamin D with Severity and Outcome of COVID-19: Clinical and Experimental Evidence},
journal = {Journal of Innate Immunity},
year = {2024},
volume = {16},
number = {1},
pages = {1--11},
doi = {10.1159/000535302}
}
EUVIMED